|
 The US specialty market reached $67.8 billion in 2010. This segment represents much of the growth in an industry that largely has experienced economic decline in recent years as many traditional branded pharmaceuticals have come off patent. While the global market for total pharmaceutical products grew 4.2 percent in 2010, sales of specialty drugs increased 7.5 percent — and are anticipated to continue to grow at a greater rate than the total pharmaceutical market.
2011 Specialty Pharmaceuticals: Facts, Figures and Trends, now in its third year, provides primary survey data from distributors and manufacturers of specialty pharmaceutical products to show trends and changes in the fastest-growing segment of the marketplace. Featuring data on market characteristics, finance, operations, cold chain management, growth in the oncology area, changes with the aging population and much more, this report provides a means for companies to benchmark their business processes, learn about the specialty segment and foresee future opportunities and challenges for this market.
Purchase your copy today!
Click here for an order form
View the table of contents
Read the press release
For more information on bulk and bundling discounts or to organize a presentation to your staff on these findings, contact Kayla Sutton at (703) 885-0285.
|